A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade
Peter G. Miller,
Adam S. Sperling,
Christopher J. Gibson,
Olga Pozdnyakova,
Waihay J. Wong,
Michael P. Manos,
Elizabeth I. Buchbinder,
F. Stephen Hodi,
Benjamin L. Ebert,
Matthew S. Davids
Affiliations
Peter G. Miller
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Adam S. Sperling
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Christopher J. Gibson
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Olga Pozdnyakova
Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Waihay J. Wong
Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Michael P. Manos
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Elizabeth I. Buchbinder
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
F. Stephen Hodi
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Benjamin L. Ebert
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA 02215
Matthew S. Davids
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
